

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 3.20194750 |
| 2 | cellular response to epinephrine stimulus (GO:0071872) | 3.17737816 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.10641840 |
| 4 | response to epinephrine (GO:0071871) | 3.05941097 |
| 5 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.04459976 |
| 6 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.01713495 |
| 7 | detection of calcium ion (GO:0005513) | 2.99637355 |
| 8 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.94889960 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.92347686 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 2.87945974 |
| 11 | macroautophagy (GO:0016236) | 2.87279074 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 2.80927553 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 2.80927553 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.80927553 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.80927553 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.80927553 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 2.80927553 |
| 18 | L-amino acid import (GO:0043092) | 2.79610382 |
| 19 | response to methylmercury (GO:0051597) | 2.75812857 |
| 20 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.74931422 |
| 21 | positive regulation of macroautophagy (GO:0016239) | 2.73745516 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 2.72739012 |
| 23 | sodium ion export (GO:0071436) | 2.71078914 |
| 24 | relaxation of cardiac muscle (GO:0055119) | 2.70888510 |
| 25 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.70825409 |
| 26 | regulation of ARF protein signal transduction (GO:0032012) | 2.69381608 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 2.68070728 |
| 28 | synaptic vesicle maturation (GO:0016188) | 2.67329959 |
| 29 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.67133188 |
| 30 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.65688700 |
| 31 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.63427814 |
| 32 | positive regulation of glycolytic process (GO:0045821) | 2.60821212 |
| 33 | vocalization behavior (GO:0071625) | 2.59973647 |
| 34 | iron ion import (GO:0097286) | 2.57643790 |
| 35 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.57080868 |
| 36 | nerve growth factor signaling pathway (GO:0038180) | 2.54754141 |
| 37 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.54576816 |
| 38 | regulation of cell communication by electrical coupling (GO:0010649) | 2.53811395 |
| 39 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.53802541 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.53345397 |
| 41 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.52822805 |
| 42 | regulation of energy homeostasis (GO:2000505) | 2.51853481 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.51376851 |
| 44 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.48133125 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.47976910 |
| 46 | synaptic vesicle exocytosis (GO:0016079) | 2.47469242 |
| 47 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.47349128 |
| 48 | glutamate secretion (GO:0014047) | 2.45578143 |
| 49 | myofibril assembly (GO:0030239) | 2.45292956 |
| 50 | regulation of protein glycosylation (GO:0060049) | 2.43695648 |
| 51 | dendrite morphogenesis (GO:0048813) | 2.39153583 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 2.38994015 |
| 53 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.38758658 |
| 54 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.38147243 |
| 55 | cellular response to ethanol (GO:0071361) | 2.37411750 |
| 56 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.36713575 |
| 57 | Golgi to endosome transport (GO:0006895) | 2.36147745 |
| 58 | * glutamate receptor signaling pathway (GO:0007215) | 2.35417773 |
| 59 | proline transport (GO:0015824) | 2.35218620 |
| 60 | negative regulation of dendrite development (GO:2000171) | 2.34462925 |
| 61 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.34293982 |
| 62 | inositol phosphate catabolic process (GO:0071545) | 2.33765268 |
| 63 | amino acid import (GO:0043090) | 2.33101875 |
| 64 | response to catecholamine (GO:0071869) | 2.30966118 |
| 65 | response to monoamine (GO:0071867) | 2.30966118 |
| 66 | regulation of actin filament-based movement (GO:1903115) | 2.30890402 |
| 67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.30754620 |
| 68 | cerebellar granule cell differentiation (GO:0021707) | 2.30728750 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.30007305 |
| 70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.29953038 |
| 71 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.27861092 |
| 72 | presynaptic membrane assembly (GO:0097105) | 2.27176130 |
| 73 | regulation of beta-amyloid formation (GO:1902003) | 2.26182174 |
| 74 | regulation of synaptic vesicle transport (GO:1902803) | 2.24607874 |
| 75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.24371469 |
| 76 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.23574109 |
| 77 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.23485659 |
| 78 | righting reflex (GO:0060013) | 2.22722936 |
| 79 | regulation of Rap GTPase activity (GO:0032317) | 2.21202690 |
| 80 | alanine transport (GO:0032328) | 2.20913323 |
| 81 | gas transport (GO:0015669) | 2.20477485 |
| 82 | presynaptic membrane organization (GO:0097090) | 2.19918576 |
| 83 | oxygen transport (GO:0015671) | 2.19482421 |
| 84 | dendritic spine morphogenesis (GO:0060997) | 2.19029313 |
| 85 | positive regulation of Rap GTPase activity (GO:0032854) | 2.18933255 |
| 86 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.17770726 |
| 87 | response to insecticide (GO:0017085) | 2.17403866 |
| 88 | protein K11-linked deubiquitination (GO:0035871) | 2.16948436 |
| 89 | regulation of cellular amide metabolic process (GO:0034248) | 2.16890233 |
| 90 | glucocorticoid metabolic process (GO:0008211) | 2.16823095 |
| 91 | positive regulation of heat generation (GO:0031652) | 2.16822287 |
| 92 | potassium ion import (GO:0010107) | 2.16646516 |
| 93 | vesicle transport along microtubule (GO:0047496) | 2.16332778 |
| 94 | protein localization to synapse (GO:0035418) | 2.16008436 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 2.15999751 |
| 96 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.15823003 |
| 97 | cellular sodium ion homeostasis (GO:0006883) | 2.15719479 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 2.15711110 |
| 99 | cell communication by electrical coupling (GO:0010644) | 2.15657866 |
| 100 | negative regulation of complement activation (GO:0045916) | 2.15517509 |
| 101 | layer formation in cerebral cortex (GO:0021819) | 2.15437302 |
| 102 | cellular response to antibiotic (GO:0071236) | 2.15154620 |
| 103 | erythrocyte development (GO:0048821) | 2.13954968 |
| 104 | neurotransmitter secretion (GO:0007269) | 2.13929323 |
| 105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.13525446 |
| 106 | exploration behavior (GO:0035640) | 2.12825195 |
| 107 | neuronal action potential propagation (GO:0019227) | 2.12061905 |
| 108 | protein targeting to Golgi (GO:0000042) | 2.12018819 |
| 109 | negative regulation of amino acid transport (GO:0051956) | 2.11941351 |
| 110 | cardiac muscle hypertrophy (GO:0003300) | 2.11859929 |
| 111 | positive regulation of p38MAPK cascade (GO:1900745) | 2.10807065 |
| 112 | response to lipoprotein particle (GO:0055094) | 2.10688320 |
| 113 | regulation of membrane repolarization (GO:0060306) | 2.10465604 |
| 114 | synaptic vesicle endocytosis (GO:0048488) | 2.09880949 |
| 115 | cardiac muscle contraction (GO:0060048) | 2.09306130 |
| 116 | brain morphogenesis (GO:0048854) | 2.08273364 |
| 117 | cellular response to catecholamine stimulus (GO:0071870) | 2.07957005 |
| 118 | cellular response to monoamine stimulus (GO:0071868) | 2.07957005 |
| 119 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.06926261 |
| 120 | positive regulation of autophagy (GO:0010508) | 2.06908412 |
| 121 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.06332204 |
| 122 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.06308519 |
| 123 | response to nerve growth factor (GO:1990089) | 2.06308519 |
| 124 | synaptic transmission, glutamatergic (GO:0035249) | 2.06114573 |
| 125 | cellular response to toxic substance (GO:0097237) | 2.06046578 |
| 126 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.02860063 |
| 127 | positive regulation of response to nutrient levels (GO:0032109) | 2.02860063 |
| 128 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.02680927 |
| 129 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.02618818 |
| 130 | striated muscle hypertrophy (GO:0014897) | 2.02374235 |
| 131 | long-term memory (GO:0007616) | 2.01857416 |
| 132 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.01680272 |
| 133 | response to host immune response (GO:0052572) | 2.01260785 |
| 134 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.01260785 |
| 135 | import into cell (GO:0098657) | 2.01133950 |
| 136 | cardiac conduction (GO:0061337) | 2.01071502 |
| 137 | insulin secretion (GO:0030073) | 1.99877266 |
| 138 | microglial cell activation (GO:0001774) | 1.99575245 |
| 139 | startle response (GO:0001964) | 1.99563694 |
| 140 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.99376480 |
| 141 | cyclic nucleotide catabolic process (GO:0009214) | 1.99347694 |
| 142 | regulation of dendritic spine development (GO:0060998) | 1.99045545 |
| 143 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.98792361 |
| 144 | establishment of protein localization to Golgi (GO:0072600) | 1.97871570 |
| 145 | neuromuscular process controlling balance (GO:0050885) | 1.97375568 |
| 146 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 1.94185272 |
| 147 | neuron-neuron synaptic transmission (GO:0007270) | 1.93286978 |
| 148 | low-density lipoprotein particle clearance (GO:0034383) | 1.92117528 |
| 149 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.92012497 |
| 150 | I-kappaB phosphorylation (GO:0007252) | 1.91821101 |
| 151 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 1.91733637 |
| 152 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 1.91310965 |
| 153 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 1.91190075 |
| 154 | regulation of synapse structural plasticity (GO:0051823) | 1.90617773 |
| 155 | membrane depolarization during action potential (GO:0086010) | 1.90293497 |
| 156 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 1.90249877 |
| 157 | negative regulation of neurotransmitter secretion (GO:0046929) | 1.90234056 |
| 158 | dicarboxylic acid biosynthetic process (GO:0043650) | 1.89257053 |
| 159 | long-term synaptic potentiation (GO:0060291) | 1.88608058 |
| 160 | hemoglobin metabolic process (GO:0020027) | 1.88554739 |
| 161 | regulation of postsynaptic membrane potential (GO:0060078) | 1.88071499 |
| 162 | acidic amino acid transport (GO:0015800) | 1.87268270 |
| 163 | negative regulation of neurotransmitter transport (GO:0051589) | 1.87115354 |
| 164 | L-glutamate transport (GO:0015813) | 1.85965146 |
| 165 | regulation of voltage-gated calcium channel activity (GO:1901385) | 1.85887268 |
| 166 | glycine transport (GO:0015816) | 1.84967595 |
| 167 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.84668430 |
| 168 | positive regulation of muscle hypertrophy (GO:0014742) | 1.84668430 |
| 169 | clathrin coat assembly (GO:0048268) | 1.84221906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.09382497 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.59867361 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.48981129 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.40642803 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.93878350 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.88485659 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.86391666 |
| 8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81439329 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.80386782 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68595224 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68320005 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65688336 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60921037 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.60745432 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.59404298 |
| 16 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.57066234 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.55312617 |
| 18 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54066028 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.51789037 |
| 20 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51584669 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50672597 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49058892 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49058892 |
| 24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.47773651 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.47505958 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.45185958 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42904128 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42604918 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40500802 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39827787 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39225572 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39135415 |
| 33 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38118932 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36453451 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34330045 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31674200 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31117217 |
| 38 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31117217 |
| 39 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.30211181 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27553647 |
| 41 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27471857 |
| 42 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26897435 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.26748234 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25673832 |
| 45 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24616605 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24506020 |
| 47 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.23701902 |
| 48 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.23212161 |
| 49 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23212161 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22568300 |
| 51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.22434972 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22184990 |
| 53 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.22122249 |
| 54 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21515299 |
| 55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21400444 |
| 56 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20934692 |
| 57 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20750302 |
| 58 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.20487490 |
| 59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.20445895 |
| 60 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20193026 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.19043504 |
| 62 | FUS_26573619_Chip-Seq_HEK293_Human | 1.18690387 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.18539964 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18097756 |
| 65 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17604809 |
| 66 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17540793 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17042879 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.16180024 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16139028 |
| 70 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.16002705 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15909998 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15692954 |
| 73 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14948374 |
| 74 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14806450 |
| 75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14525180 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12756538 |
| 77 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12135494 |
| 78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11807679 |
| 79 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11450006 |
| 80 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.11399209 |
| 81 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11101865 |
| 82 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10851015 |
| 83 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10677110 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.10466016 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09954155 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09312031 |
| 87 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08931688 |
| 88 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.08758519 |
| 89 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08735841 |
| 90 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08626485 |
| 91 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08230864 |
| 92 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08152522 |
| 93 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07709552 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07560710 |
| 95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06762882 |
| 96 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.05539134 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05323192 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05238551 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04994881 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04521671 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04146376 |
| 102 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04040085 |
| 103 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.03910288 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03837823 |
| 105 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02679914 |
| 106 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02019130 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01828952 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01788648 |
| 109 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01510388 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00914829 |
| 111 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00780423 |
| 112 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00042394 |
| 113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99982672 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99921582 |
| 115 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99921582 |
| 116 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99733397 |
| 117 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99699905 |
| 118 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99537017 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98869381 |
| 120 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98745712 |
| 121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98495206 |
| 122 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97601013 |
| 123 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97592859 |
| 124 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97090576 |
| 125 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96563921 |
| 126 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96560717 |
| 127 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96270336 |
| 128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96143173 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95790845 |
| 130 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95715082 |
| 131 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.95236964 |
| 132 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95178306 |
| 133 | AR_19668381_ChIP-Seq_PC3_Human | 0.94786067 |
| 134 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.94696303 |
| 135 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.92855946 |
| 136 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91341185 |
| 137 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91273554 |
| 138 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90054414 |
| 139 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89993200 |
| 140 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89919829 |
| 141 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88783112 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88662005 |
| 143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87831883 |
| 144 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85865811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.18622059 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 2.99581521 |
| 3 | MP0004270_analgesia | 2.73246731 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.67018264 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.58465288 |
| 6 | MP0009046_muscle_twitch | 2.56663430 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 2.48824990 |
| 8 | MP0003880_abnormal_central_pattern | 2.46860140 |
| 9 | MP0003690_abnormal_glial_cell | 2.31372871 |
| 10 | MP0001501_abnormal_sleep_pattern | 2.18294566 |
| 11 | MP0002064_seizures | 2.16901713 |
| 12 | MP0009745_abnormal_behavioral_response | 2.13990272 |
| 13 | MP0000604_amyloidosis | 2.10898940 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.05535527 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.03861873 |
| 16 | MP0004510_myositis | 2.02773135 |
| 17 | MP0003787_abnormal_imprinting | 2.01333662 |
| 18 | MP0004215_abnormal_myocardial_fiber | 1.98032349 |
| 19 | MP0003329_amyloid_beta_deposits | 1.97720633 |
| 20 | MP0004147_increased_porphyrin_level | 1.96707986 |
| 21 | MP0003303_peritoneal_inflammation | 1.95728161 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.88532049 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.87073741 |
| 24 | MP0004858_abnormal_nervous_system | 1.86242911 |
| 25 | MP0003172_abnormal_lysosome_physiology | 1.84507636 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.79811920 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 1.79223964 |
| 28 | MP0003075_altered_response_to | 1.79223720 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.71905180 |
| 30 | MP0003195_calcinosis | 1.68001206 |
| 31 | MP0001486_abnormal_startle_reflex | 1.67294821 |
| 32 | MP0004130_abnormal_muscle_cell | 1.66248438 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.65960561 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.62011636 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.61492109 |
| 36 | MP0003122_maternal_imprinting | 1.59434623 |
| 37 | MP0001968_abnormal_touch/_nociception | 1.59293322 |
| 38 | MP0005360_urolithiasis | 1.53194642 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.46848056 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.44770912 |
| 41 | MP0003633_abnormal_nervous_system | 1.43668938 |
| 42 | MP0004036_abnormal_muscle_relaxation | 1.43642606 |
| 43 | MP0000920_abnormal_myelination | 1.41509719 |
| 44 | MP0005083_abnormal_biliary_tract | 1.41044342 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.40877672 |
| 46 | MP0005535_abnormal_body_temperature | 1.40270353 |
| 47 | MP0005167_abnormal_blood-brain_barrier | 1.39097492 |
| 48 | MP0002272_abnormal_nervous_system | 1.37802692 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.37530805 |
| 50 | MP0002067_abnormal_sensory_capabilities | 1.35248654 |
| 51 | MP0003646_muscle_fatigue | 1.34113669 |
| 52 | MP0004043_abnormal_pH_regulation | 1.33503763 |
| 53 | MP0005423_abnormal_somatic_nervous | 1.28866064 |
| 54 | MP0003300_gastrointestinal_ulcer | 1.27007368 |
| 55 | MP0002254_reproductive_system_inflammat | 1.24953200 |
| 56 | MP0006082_CNS_inflammation | 1.24527653 |
| 57 | MP0002736_abnormal_nociception_after | 1.22699568 |
| 58 | MP0008057_abnormal_DNA_replication | 1.22398127 |
| 59 | MP0002090_abnormal_vision | 1.22082843 |
| 60 | MP0004924_abnormal_behavior | 1.21690871 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.21690871 |
| 62 | MP0003634_abnormal_glial_cell | 1.21328037 |
| 63 | MP0000013_abnormal_adipose_tissue | 1.18802550 |
| 64 | MP0001970_abnormal_pain_threshold | 1.17855575 |
| 65 | MP0009764_decreased_sensitivity_to | 1.16978520 |
| 66 | MP0003631_nervous_system_phenotype | 1.14738986 |
| 67 | MP0008569_lethality_at_weaning | 1.14577570 |
| 68 | MP0004885_abnormal_endolymph | 1.14167012 |
| 69 | MP0000749_muscle_degeneration | 1.14163106 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.12837418 |
| 71 | MP0005646_abnormal_pituitary_gland | 1.12439687 |
| 72 | MP0010386_abnormal_urinary_bladder | 1.12032855 |
| 73 | MP0001502_abnormal_circadian_rhythm | 1.10263533 |
| 74 | MP0005620_abnormal_muscle_contractility | 1.10169974 |
| 75 | MP0001756_abnormal_urination | 1.09436205 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.07826427 |
| 77 | MP0000778_abnormal_nervous_system | 1.07031588 |
| 78 | MP0002822_catalepsy | 1.06936716 |
| 79 | MP0002693_abnormal_pancreas_physiology | 1.03969658 |
| 80 | MP0005166_decreased_susceptibility_to | 1.03337937 |
| 81 | MP0005248_abnormal_Harderian_gland | 1.02498667 |
| 82 | MP0000639_abnormal_adrenal_gland | 1.01898818 |
| 83 | MP0003724_increased_susceptibility_to | 1.01292423 |
| 84 | MP0002638_abnormal_pupillary_reflex | 1.00973488 |
| 85 | MP0001944_abnormal_pancreas_morphology | 1.00619306 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.99771212 |
| 87 | MP0002229_neurodegeneration | 0.99120798 |
| 88 | MP0003252_abnormal_bile_duct | 0.98840813 |
| 89 | MP0008004_abnormal_stomach_pH | 0.98048268 |
| 90 | MP0010329_abnormal_lipoprotein_level | 0.97298453 |
| 91 | MP0003045_fibrosis | 0.96884370 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.96851241 |
| 93 | MP0004811_abnormal_neuron_physiology | 0.96844882 |
| 94 | MP0005085_abnormal_gallbladder_physiolo | 0.96829272 |
| 95 | MP0003879_abnormal_hair_cell | 0.95875294 |
| 96 | MP0004142_abnormal_muscle_tone | 0.95822561 |
| 97 | MP0005253_abnormal_eye_physiology | 0.95536132 |
| 98 | MP0008874_decreased_physiological_sensi | 0.92346233 |
| 99 | MP0003436_decreased_susceptibility_to | 0.91156465 |
| 100 | MP0005365_abnormal_bile_salt | 0.90608454 |
| 101 | MP0003868_abnormal_feces_composition | 0.90513617 |
| 102 | MP0003632_abnormal_nervous_system | 0.90433550 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.89736674 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.89636321 |
| 105 | MP0002419_abnormal_innate_immunity | 0.89631059 |
| 106 | MP0005187_abnormal_penis_morphology | 0.88751397 |
| 107 | MP0004742_abnormal_vestibular_system | 0.88649399 |
| 108 | MP0002066_abnormal_motor_capabilities/c | 0.88480908 |
| 109 | MP0005636_abnormal_mineral_homeostasis | 0.85689485 |
| 110 | MP0003011_delayed_dark_adaptation | 0.84242714 |
| 111 | MP0008877_abnormal_DNA_methylation | 0.83409683 |
| 112 | MP0010678_abnormal_skin_adnexa | 0.81454700 |
| 113 | MP0002168_other_aberrant_phenotype | 0.79252565 |
| 114 | MP0000955_abnormal_spinal_cord | 0.78090712 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.77585256 |
| 116 | MP0005448_abnormal_energy_balance | 0.77466092 |
| 117 | MP0002882_abnormal_neuron_morphology | 0.77316998 |
| 118 | MP0002971_abnormal_brown_adipose | 0.77303641 |
| 119 | MP0004484_altered_response_of | 0.76990367 |
| 120 | MP0002184_abnormal_innervation | 0.76226964 |
| 121 | MP0004085_abnormal_heartbeat | 0.76110901 |
| 122 | MP0005551_abnormal_eye_electrophysiolog | 0.75933915 |
| 123 | MP0005310_abnormal_salivary_gland | 0.75777187 |
| 124 | MP0002557_abnormal_social/conspecific_i | 0.75069836 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.74942997 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.74669046 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.73364720 |
| 128 | MP0003953_abnormal_hormone_level | 0.71717102 |
| 129 | MP0005164_abnormal_response_to | 0.70334234 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.69765721 |
| 131 | MP0005645_abnormal_hypothalamus_physiol | 0.69616775 |
| 132 | MP0008260_abnormal_autophagy | 0.68414929 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67760798 |
| 134 | MP0001984_abnormal_olfaction | 0.67649552 |
| 135 | MP0006276_abnormal_autonomic_nervous | 0.67571930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 3.93085490 |
| 2 | Papillary thyroid carcinoma (HP:0002895) | 3.74206662 |
| 3 | Focal seizures (HP:0007359) | 3.57379205 |
| 4 | Poikilocytosis (HP:0004447) | 3.37849158 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.22196735 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.20816982 |
| 7 | Action tremor (HP:0002345) | 3.10216513 |
| 8 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.08891974 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.05285435 |
| 10 | Syncope (HP:0001279) | 2.99455479 |
| 11 | Bundle branch block (HP:0011710) | 2.95147273 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94024137 |
| 13 | Myokymia (HP:0002411) | 2.93410222 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 2.92998347 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 2.88819407 |
| 16 | Hypochromic microcytic anemia (HP:0004840) | 2.87726994 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 2.86516358 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 2.83910003 |
| 19 | Visual hallucinations (HP:0002367) | 2.83420371 |
| 20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.82557718 |
| 21 | Difficulty running (HP:0009046) | 2.80665785 |
| 22 | Febrile seizures (HP:0002373) | 2.80650012 |
| 23 | Thyroid carcinoma (HP:0002890) | 2.80607526 |
| 24 | Axonal loss (HP:0003447) | 2.78569294 |
| 25 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.74906154 |
| 26 | Acanthocytosis (HP:0001927) | 2.74624958 |
| 27 | Ventricular fibrillation (HP:0001663) | 2.74104053 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 2.70602724 |
| 29 | Increased circulating renin level (HP:0000848) | 2.65473281 |
| 30 | Hyperglycemia (HP:0003074) | 2.63244912 |
| 31 | Dialeptic seizures (HP:0011146) | 2.61945213 |
| 32 | Absence seizures (HP:0002121) | 2.61525960 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.60615941 |
| 34 | Cholelithiasis (HP:0001081) | 2.56686075 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 2.56047474 |
| 36 | Ketoacidosis (HP:0001993) | 2.51008823 |
| 37 | Hypothermia (HP:0002045) | 2.50269332 |
| 38 | Hemiparesis (HP:0001269) | 2.48362340 |
| 39 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.48179092 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47240762 |
| 41 | Fair hair (HP:0002286) | 2.45356005 |
| 42 | Abnormal gallbladder morphology (HP:0012437) | 2.44515436 |
| 43 | Diplopia (HP:0000651) | 2.44333857 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.44333857 |
| 45 | Excessive salivation (HP:0003781) | 2.42178079 |
| 46 | Drooling (HP:0002307) | 2.42178079 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42125810 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.41928517 |
| 49 | Reticulocytosis (HP:0001923) | 2.41301450 |
| 50 | Sudden death (HP:0001699) | 2.39869630 |
| 51 | Clumsiness (HP:0002312) | 2.39263512 |
| 52 | Pheochromocytoma (HP:0002666) | 2.38780489 |
| 53 | Hyperkalemia (HP:0002153) | 2.38043465 |
| 54 | Postural instability (HP:0002172) | 2.35215661 |
| 55 | Atonic seizures (HP:0010819) | 2.30788105 |
| 56 | Hyperventilation (HP:0002883) | 2.30695604 |
| 57 | Hypsarrhythmia (HP:0002521) | 2.29848653 |
| 58 | Abnormality of the calf musculature (HP:0001430) | 2.28593743 |
| 59 | Generalized hypopigmentation of hair (HP:0011358) | 2.27784170 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.24469081 |
| 61 | Dysmetria (HP:0001310) | 2.23770275 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.22537020 |
| 63 | Testicular neoplasm (HP:0010788) | 2.22038874 |
| 64 | Blue irides (HP:0000635) | 2.21622845 |
| 65 | Decreased circulating renin level (HP:0003351) | 2.20130427 |
| 66 | Muscle fiber splitting (HP:0003555) | 2.19843994 |
| 67 | Status epilepticus (HP:0002133) | 2.19817381 |
| 68 | Eczematoid dermatitis (HP:0000976) | 2.19760838 |
| 69 | Progressive inability to walk (HP:0002505) | 2.18030592 |
| 70 | Neuroendocrine neoplasm (HP:0100634) | 2.17652423 |
| 71 | Tetraparesis (HP:0002273) | 2.17615582 |
| 72 | Abnormal social behavior (HP:0012433) | 2.17399082 |
| 73 | Impaired social interactions (HP:0000735) | 2.17399082 |
| 74 | Atrial fibrillation (HP:0005110) | 2.16380699 |
| 75 | Spastic tetraparesis (HP:0001285) | 2.13369570 |
| 76 | Hypokalemic alkalosis (HP:0001949) | 2.10962434 |
| 77 | Global brain atrophy (HP:0002283) | 2.10603307 |
| 78 | Fetal akinesia sequence (HP:0001989) | 2.10156494 |
| 79 | Confusion (HP:0001289) | 2.10122416 |
| 80 | Dysdiadochokinesis (HP:0002075) | 2.10110118 |
| 81 | Ventricular arrhythmia (HP:0004308) | 2.09794999 |
| 82 | Primary atrial arrhythmia (HP:0001692) | 2.09496406 |
| 83 | Gaze-evoked nystagmus (HP:0000640) | 2.09341262 |
| 84 | Intention tremor (HP:0002080) | 2.08693599 |
| 85 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08051599 |
| 86 | Frequent falls (HP:0002359) | 2.07735300 |
| 87 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.07580644 |
| 88 | Subaortic stenosis (HP:0001682) | 2.07580644 |
| 89 | Prolonged QT interval (HP:0001657) | 2.07462156 |
| 90 | Abnormality of macrophages (HP:0004311) | 2.07300705 |
| 91 | Agitation (HP:0000713) | 2.07030404 |
| 92 | Depression (HP:0000716) | 2.03934576 |
| 93 | Broad-based gait (HP:0002136) | 2.03112541 |
| 94 | Genetic anticipation (HP:0003743) | 2.02488848 |
| 95 | Mutism (HP:0002300) | 2.02385825 |
| 96 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.02249645 |
| 97 | EMG: myopathic abnormalities (HP:0003458) | 2.02001274 |
| 98 | Hypoglycemic coma (HP:0001325) | 1.99645735 |
| 99 | Inappropriate behavior (HP:0000719) | 1.99403187 |
| 100 | Widely spaced teeth (HP:0000687) | 1.97743555 |
| 101 | Disinhibition (HP:0000734) | 1.97585072 |
| 102 | Hyperaldosteronism (HP:0000859) | 1.97297040 |
| 103 | Hematochezia (HP:0002573) | 1.97144423 |
| 104 | Large for gestational age (HP:0001520) | 1.97079515 |
| 105 | Hamartoma of the eye (HP:0010568) | 1.97034685 |
| 106 | Absent speech (HP:0001344) | 1.96952527 |
| 107 | Albinism (HP:0001022) | 1.96352841 |
| 108 | Onion bulb formation (HP:0003383) | 1.95479369 |
| 109 | Neuronal loss in central nervous system (HP:0002529) | 1.94749967 |
| 110 | Anxiety (HP:0000739) | 1.94296140 |
| 111 | Dysmetric saccades (HP:0000641) | 1.94179761 |
| 112 | Abnormal EKG (HP:0003115) | 1.94083759 |
| 113 | Postural tremor (HP:0002174) | 1.93831227 |
| 114 | Truncal ataxia (HP:0002078) | 1.93825802 |
| 115 | Increased CSF protein (HP:0002922) | 1.93340233 |
| 116 | Congenital sensorineural hearing impairment (HP:0008527) | 1.92552495 |
| 117 | Microcytic anemia (HP:0001935) | 1.92347394 |
| 118 | Enlarged penis (HP:0000040) | 1.92082069 |
| 119 | Amyloidosis (HP:0011034) | 1.91992863 |
| 120 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.91570535 |
| 121 | Poor eye contact (HP:0000817) | 1.90728751 |
| 122 | Myocardial infarction (HP:0001658) | 1.89759806 |
| 123 | Dysostosis multiplex (HP:0000943) | 1.88386789 |
| 124 | Supraventricular tachycardia (HP:0004755) | 1.86798019 |
| 125 | Hypomagnesemia (HP:0002917) | 1.86704834 |
| 126 | Abnormality of the corticospinal tract (HP:0002492) | 1.86461146 |
| 127 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86166899 |
| 128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86166899 |
| 129 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86166899 |
| 130 | Progressive visual loss (HP:0000529) | 1.85713141 |
| 131 | Stomatitis (HP:0010280) | 1.84872952 |
| 132 | Peripheral demyelination (HP:0011096) | 1.84298728 |
| 133 | Abnormality of potassium homeostasis (HP:0011042) | 1.83349832 |
| 134 | Gingivitis (HP:0000230) | 1.83219709 |
| 135 | Retinal atrophy (HP:0001105) | 1.82766862 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.82691609 |
| 137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82691609 |
| 138 | Protruding tongue (HP:0010808) | 1.82249160 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.81457589 |
| 140 | Exercise-induced myalgia (HP:0003738) | 1.80998712 |
| 141 | EMG: neuropathic changes (HP:0003445) | 1.80537978 |
| 142 | Abnormality of salivation (HP:0100755) | 1.80536141 |
| 143 | Macroorchidism (HP:0000053) | 1.78612831 |
| 144 | Supraventricular arrhythmia (HP:0005115) | 1.78277389 |
| 145 | Sensorimotor neuropathy (HP:0007141) | 1.78013499 |
| 146 | Epidermoid cyst (HP:0200040) | 1.77942131 |
| 147 | Insidious onset (HP:0003587) | 1.77756416 |
| 148 | Termporal pattern (HP:0011008) | 1.77756416 |
| 149 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.77258377 |
| 150 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.77258377 |
| 151 | Abnormality of the periventricular white matter (HP:0002518) | 1.76972110 |
| 152 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76665079 |
| 153 | Asymmetric septal hypertrophy (HP:0001670) | 1.76254144 |
| 154 | Abnormal eating behavior (HP:0100738) | 1.75799864 |
| 155 | Xanthomatosis (HP:0000991) | 1.75663552 |
| 156 | Psychosis (HP:0000709) | 1.74145864 |
| 157 | Abnormality of saccadic eye movements (HP:0000570) | 1.73588916 |
| 158 | Hypoalphalipoproteinemia (HP:0003233) | 1.73219851 |
| 159 | Papilledema (HP:0001085) | 1.71778762 |
| 160 | Lower limb muscle weakness (HP:0007340) | 1.70835160 |
| 161 | Thick nail (HP:0001805) | 1.70575002 |
| 162 | Hemiplegia (HP:0002301) | 1.70324419 |
| 163 | Lower limb amyotrophy (HP:0007210) | 1.68608875 |
| 164 | Abnormality of the gallbladder (HP:0005264) | 1.67674474 |
| 165 | Epileptiform EEG discharges (HP:0011182) | 1.66889040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.55361713 |
| 2 | EPHA4 | 2.68869456 |
| 3 | DAPK2 | 2.67319319 |
| 4 | NTRK3 | 2.61757316 |
| 5 | OBSCN | 2.51599697 |
| 6 | AKT3 | 2.45760355 |
| 7 | MARK1 | 2.11563321 |
| 8 | MAP3K9 | 1.90352147 |
| 9 | PAK6 | 1.74369479 |
| 10 | KSR2 | 1.73364183 |
| 11 | MAP3K4 | 1.71990088 |
| 12 | CAMK1G | 1.69557082 |
| 13 | MAP2K4 | 1.63000423 |
| 14 | NTRK1 | 1.61992668 |
| 15 | SGK2 | 1.60052952 |
| 16 | SGK3 | 1.58758597 |
| 17 | MAP3K14 | 1.55779502 |
| 18 | SGK494 | 1.51795014 |
| 19 | SGK223 | 1.51795014 |
| 20 | MAP3K13 | 1.50856754 |
| 21 | EPHA3 | 1.44795593 |
| 22 | MAP3K2 | 1.43901941 |
| 23 | TRPM7 | 1.39654969 |
| 24 | CAMK1D | 1.33966728 |
| 25 | PINK1 | 1.33886375 |
| 26 | STK24 | 1.29861831 |
| 27 | INSRR | 1.26767005 |
| 28 | CASK | 1.26250045 |
| 29 | TNIK | 1.24847036 |
| 30 | ACVR1B | 1.24481925 |
| 31 | FGR | 1.22516774 |
| 32 | NTRK2 | 1.21793750 |
| 33 | RIPK1 | 1.21582580 |
| 34 | ERBB4 | 1.19335260 |
| 35 | TAOK3 | 1.18078419 |
| 36 | SGK1 | 1.16962231 |
| 37 | MINK1 | 1.16610325 |
| 38 | JAK1 | 1.16395033 |
| 39 | CAMKK1 | 1.13596819 |
| 40 | MAP2K7 | 1.11664669 |
| 41 | MAPK13 | 1.10509525 |
| 42 | PTK2B | 1.10027133 |
| 43 | ERBB3 | 1.08620344 |
| 44 | RET | 1.07507951 |
| 45 | CDK5 | 1.06942163 |
| 46 | PDPK1 | 1.04884311 |
| 47 | PHKG2 | 1.03601692 |
| 48 | PHKG1 | 1.03601692 |
| 49 | BMX | 1.03254271 |
| 50 | CAMKK2 | 1.02529850 |
| 51 | FER | 1.01723564 |
| 52 | NLK | 1.00663496 |
| 53 | PKN1 | 0.99027991 |
| 54 | SIK2 | 0.98639930 |
| 55 | IRAK3 | 0.98484470 |
| 56 | WNK1 | 0.98347518 |
| 57 | PLK2 | 0.97142805 |
| 58 | IRAK1 | 0.95949639 |
| 59 | PRPF4B | 0.95159291 |
| 60 | TBK1 | 0.94502185 |
| 61 | PRKCH | 0.93672304 |
| 62 | YES1 | 0.91974359 |
| 63 | GRK5 | 0.89720992 |
| 64 | STK38L | 0.89190695 |
| 65 | CAMK4 | 0.88918945 |
| 66 | MAP3K3 | 0.86510275 |
| 67 | PDK1 | 0.86030057 |
| 68 | EPHB1 | 0.85503415 |
| 69 | MST1R | 0.83077240 |
| 70 | KSR1 | 0.82859140 |
| 71 | OXSR1 | 0.82422930 |
| 72 | JAK2 | 0.80691227 |
| 73 | IKBKE | 0.80458489 |
| 74 | PBK | 0.77098460 |
| 75 | MAPK12 | 0.75874806 |
| 76 | DYRK1A | 0.74340673 |
| 77 | DMPK | 0.74235988 |
| 78 | BMPR2 | 0.74071095 |
| 79 | PRKAA1 | 0.73159613 |
| 80 | PDGFRB | 0.70314808 |
| 81 | CAMK2A | 0.69974665 |
| 82 | HIPK2 | 0.69562842 |
| 83 | MAP3K6 | 0.69048093 |
| 84 | PRKCE | 0.68948002 |
| 85 | CAMK1 | 0.66192571 |
| 86 | FGFR2 | 0.64672455 |
| 87 | STK38 | 0.64656078 |
| 88 | BMPR1B | 0.64549786 |
| 89 | FRK | 0.64449729 |
| 90 | PRKD3 | 0.63392054 |
| 91 | MAP3K5 | 0.63124136 |
| 92 | UHMK1 | 0.62726786 |
| 93 | TYRO3 | 0.61284050 |
| 94 | FES | 0.61234089 |
| 95 | WNK4 | 0.60788600 |
| 96 | PRKCG | 0.59574168 |
| 97 | CAMK2D | 0.59527418 |
| 98 | PDK2 | 0.59378090 |
| 99 | PRKAA2 | 0.58496716 |
| 100 | PRKCZ | 0.58381413 |
| 101 | ABL2 | 0.58337523 |
| 102 | PAK3 | 0.57901293 |
| 103 | STK3 | 0.57868349 |
| 104 | MST4 | 0.57523632 |
| 105 | MAP2K1 | 0.57295940 |
| 106 | STK11 | 0.56720144 |
| 107 | MAP3K1 | 0.56493502 |
| 108 | IRAK2 | 0.56284040 |
| 109 | SIK1 | 0.55389920 |
| 110 | FGFR3 | 0.54829017 |
| 111 | FYN | 0.53870389 |
| 112 | MAP3K7 | 0.53576161 |
| 113 | BLK | 0.53062149 |
| 114 | RPS6KA3 | 0.52898105 |
| 115 | ERBB2 | 0.51496242 |
| 116 | PRKCQ | 0.51349125 |
| 117 | MAP4K2 | 0.50876114 |
| 118 | EIF2AK1 | 0.50346023 |
| 119 | TRIB3 | 0.50207941 |
| 120 | MARK3 | 0.49696441 |
| 121 | TYK2 | 0.49550067 |
| 122 | CHUK | 0.49312608 |
| 123 | CDC42BPA | 0.49001779 |
| 124 | WNK3 | 0.48536620 |
| 125 | PIK3CA | 0.48380046 |
| 126 | MAP2K3 | 0.48030317 |
| 127 | STK39 | 0.47690588 |
| 128 | EGFR | 0.47577501 |
| 129 | PRKACG | 0.47480102 |
| 130 | TAOK1 | 0.47265069 |
| 131 | MUSK | 0.47094322 |
| 132 | LATS1 | 0.46284329 |
| 133 | DAPK1 | 0.46097259 |
| 134 | NEK6 | 0.46045669 |
| 135 | GRK7 | 0.44929489 |
| 136 | MAPK7 | 0.44744809 |
| 137 | PRKG1 | 0.44249334 |
| 138 | PIM1 | 0.43970125 |
| 139 | CSNK1G2 | 0.41990382 |
| 140 | STK4 | 0.41108125 |
| 141 | CAMK2B | 0.39924168 |
| 142 | BRD4 | 0.39634151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.31017488 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.25523630 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 1.76666699 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.75361625 |
| 5 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.61467644 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53550443 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43544484 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.43127519 |
| 9 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41831181 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.39915912 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.39516364 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38379049 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.36853434 |
| 14 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.36584034 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.30355046 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.30007844 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.25538820 |
| 18 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.25072937 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.20376209 |
| 20 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.15206023 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.14824914 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10289475 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07016128 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06937894 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.06589237 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05867548 |
| 27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03501640 |
| 28 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00019859 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99647814 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98177085 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 0.97841768 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 0.95552969 |
| 33 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95361914 |
| 34 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94317485 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94105185 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91732577 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90714158 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90174452 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89764156 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 0.88935324 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88850123 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.88044509 |
| 43 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87406147 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 0.87030790 |
| 45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86865966 |
| 46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86436919 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86006092 |
| 48 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85238248 |
| 49 | Malaria_Homo sapiens_hsa05144 | 0.83175136 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80691914 |
| 51 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80585133 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80304420 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80154351 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79202917 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.78586456 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 0.78067299 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.78042110 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77780875 |
| 59 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.76747937 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75722870 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75605883 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75500345 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73292227 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73079359 |
| 65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72282598 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72190302 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.71801082 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.71508866 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.71439699 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71223021 |
| 71 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71165660 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71142754 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70976369 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70976160 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70886151 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69781849 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68481826 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.66707618 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.65469705 |
| 80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64715047 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64388036 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64233156 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62445494 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62234847 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60860548 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60492216 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60221054 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59973701 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59464787 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58980346 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.58658955 |
| 92 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58637861 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57939089 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57801807 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.55272900 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54872155 |
| 97 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54274281 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53939141 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53918760 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.53897278 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53092408 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.52852177 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52172491 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52069950 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51814090 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51362636 |
| 107 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49958233 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.49952541 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.49819627 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49416956 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49004403 |
| 112 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48943482 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.47879344 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47776989 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47706854 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47671533 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47666894 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47444920 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46398279 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45221651 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44716387 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.43846963 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43401336 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43279537 |
| 125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43115302 |
| 126 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41266556 |
| 127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41156497 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39470387 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39435055 |

